Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Fungal Group Zygomycota

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...

Skin Diseases and Disorders

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

Antifungal Agents

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

Fungal Phylum Ascomycota

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...

Fungal Phylum Basidiomycota

Fungal Phylum Basidiomycota

Basidiomycota is a diverse phylum of fungi that includes ecologically significant decomposers such as white rot fungi, symbionts like mycorrhizal fungi, plant pathogens such as rusts and smuts, and edible species like Agaricus bisporus (the common button mushroom). These fungi play crucial roles in nutrient cycling, symbiotic relationships, and even human health. Their defining feature is the basidium, a microscopic club-shaped structure responsible for producing basidiospores.Fruiting Bodies...

Fungal Phylum Microsporidia

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adrenomedullin Therapy for Moderate-to-Severe COVID-19 Pneumonia: Double-Blind Placebo-Controlled Phase 2a Trial.

Viruses·2025

Same author

Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.

Proceedings of the National Academy of Sciences of the United States of America·2023

Same author

Two cases of systemic capillary leak syndrome associated with COVID-19 in Japan.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2023

Same author

Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants.

Nature communications·2023

Same author

Specific COVID-19 risk behaviors and the preventive effect of personal protective equipment among healthcare workers in Japan.

Global health & medicine·2023

Same author

Non-serogroupable <i>Neisseria meningitidis</i> pneumonia in an immunocompetent patient with severe COVID-19 pneumonia: A case report.

IDCases·2022

Search research articles

Related Experiment Video

Updated: May 21, 2026

Sexual Crosses with the Mucoromycete Phycomyces blakesleeanus

Sexual Crosses with the Mucoromycete Phycomyces blakesleeanus

Published on: June 6, 2025

[Mucormycosis].

Fukumi Nakamura-Uchiyama¹

¹Department of Infectious Diseases, Tokyo Metropolitan Bokutoh Hospital.

Brain and Nerve = Shinkei Kenkyu No Shinpo

|May 19, 2026

Summary

Early diagnosis and treatment of mucormycosis, a serious fungal infection in immunocompromised patients, are crucial. Treatment combines surgery, antifungal medications like Amphotericin B, and managing underlying conditions for better outcomes.

Area of Science:

Mycology
Infectious Diseases
Immunocompromised Host Research

Background:

Mucormycosis presents a significant challenge with a poor prognosis, particularly in immunocompromised individuals.
Rhino-orbital cerebral mucormycosis is a severe form that rapidly spreads from the nasal cavity to adjacent structures.
The diverse symptoms necessitate early consideration and prompt diagnostic evaluation in at-risk patients.

Purpose of the Study:

To highlight the critical importance of early diagnosis and management of mucormycosis.
To outline the primary therapeutic strategies for this invasive fungal infection.
To emphasize the role of specific antifungal agents in treatment protocols.

Main Methods:

Review of clinical presentation and diagnostic considerations for rhino-orbital cerebral mucormycosis.

Related Experiment Videos

Last Updated: May 21, 2026

Sexual Crosses with the Mucoromycete Phycomyces blakesleeanus

Sexual Crosses with the Mucoromycete Phycomyces blakesleeanus

Published on: June 6, 2025

Analysis of established treatment guidelines, including surgical and medical interventions.

Focus on the role of Amphotericin B liposomal preparations as a first-line antifungal therapy.

Main Results:

Successful management hinges on a multi-faceted approach involving surgical debridement, antifungal therapy, and control of predisposing factors.
Amphotericin B liposomal preparations are identified as the preferred initial antifungal agent.
Antifungal treatment requires a prolonged duration for effective disease control.

Conclusions:

Prompt diagnosis and aggressive management are essential for improving the prognosis of mucormycosis in immunocompromised patients.
A combination of surgical intervention, targeted antifungal therapy, and management of underlying conditions is the cornerstone of treatment.
Long-term antifungal administration is a critical component of the therapeutic regimen.